National Food and Drug Administration deploys H7N9 influenza prevention and control

On April 9th, Zhang Yong, director of the CFDA and party secretary, presided over a meeting to study and deploy plans to respond to human infection with the H7N9 bird flu epidemic.

It is reported that in response to the recent outbreak of human infection with H7N9 bird flu, the State Food and Drug Administration has rapidly deployed and actively responded to it. On the one hand, early intervention and research and development, enhanced communication and guidance were adopted to speed up the approval and listing of related prevention and control drugs on the premise of ensuring safety and effectiveness. On April 5, the new anti-influenza virus drug paramivir was approved. Sodium chloride injection. On the other hand, we must strengthen the supervision and inspection of key links in the production and management of related drugs and medical devices, and resolutely deal with violations of laws and regulations in accordance with law. On April 8, the State Food and Drug Administration issued and issued the “Notice of the General Office of the State Food and Drug Administration to Strengthen the Supervision and Control of Medical Devices for Influenza Prevention and Control of Medical Protective Masks and Medical Protective Clothing” to strengthen the H7N9 influenza prevention and control medical device. Regulatory work is fully deployed.

Zhang Yong pointed out that in the next step, the food and drug supervision departments must conscientiously implement the requirements for prevention and control of the epidemic, follow the division of responsibilities of the joint prevention and control work mechanism, attach great importance to it, take the initiative, cooperate closely, guide it correctly, and follow laws and regulations to ensure prevention and control. Drugs and medical devices quality and safety. It is necessary to strengthen propaganda for the scientific use of influenza prevention and treatment drugs and strengthen the monitoring of adverse reactions to clinical use of drugs; it is necessary to actively cooperate with relevant departments to meet the needs of clinically relevant diagnostic reagents and prepare for review approval; Vaccine development and clinical trials related work to speed up the process of vaccine listing; to coordinate food safety supervision work; food and drug regulatory authorities around the country to ensure the smooth flow of information reporting channels, timely reporting to food and drug regulatory agencies to prevent and control flu epidemic situation related work .